Analysis of the Clinical Curative Effect of Hepatic Artery Embolism Chemotherapy Combined with Portal Vein Chemotherapy on Patients after the Surgery of Hepatic Carcinoma with Portal Vein Tumor Emboli
Wusheng YU,Zaiguo WANG,Xingzhao LU,Zhiming WU,Zhiqiang LIN,Xiarong HU,Jianhua CHEN,Rongping GUO
DOI: https://doi.org/10.3969/j.issn.1674-0742.2014.28.009
2014-01-01
Abstract:Objective To explore the effective measures for the prevention of recurrence and improve the survival of the patients after the surgery of hepatic carcinoma with portal vein tumor emboli. Methods The patients underwent the surgery of resection of hepatocellular carcinoma with portal vein tumor emboli were selected as the subjects and randomly divided into 4 groups:group A only received the operation for excision, group B underwent the operation and hepatic artery chemoembolization; group C received the operation and portal vein chemotherapy; group D underwent the operation and sequential combination of hepatic artery chemoembolization and portal vein chemotherapy. And the overall 1, 2, 3 years of survival rate was compared between the four groups. Results The overall 0.5, 1, 2, 3 years of survival rate of group A was 44.4%, 27.8%, 11.1%, 5.0%, respectively; and that of group B was 56.0%, 44.0%, 28.0%, 20.0%, respectively;that of group C was 54.5%, 40.9%, 27.3%, 18.2%, respectively;that of group D was 69.2%, 53.8%, 42.3%, 30.7%, respectively. The overall survival rates of group D were significantly higher than those of the other groups (P<0.05), the differences in survival rates between group B and group C were not statistically significant (P>0.05), while the survival rates of group A were significantly lower than those of the other groups (P<0.05). Conclusion Postopera-tive hepatic artery chemoembolization and portal vein chemotherapy are effective methods for reducing the postoperative recurrence of patients with hepatic carcinoma and portal vein tumor emboli, and the application of combination of them is of great clinical sig-nificance in further reducing the postoperative recurrence and improving the survival rate of the patients.